Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine to reduce onset time of rocuronium in elderly patients
2024-517933-42-00Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ephedrine (2 arms), sponsored by Rigshospitalet. Primary endpoint: Time to TOF 0. Started Nov 2024; status: completed.
02
Drugs
ephedrine
Beyond the preview
Go deeper on 2024-517933-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517933-42-00.